- Home
- INFU vs PRE Comparison
INFU vs PRE Comparison
Compare INFU & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- PRE
- Stock Information
- Founded
- INFU 2005
- PRE 2014
- Country
- INFU United States
- PRE Hong Kong
- Employees
- INFU N/A
- PRE N/A
- Industry
- INFU Medical/Dental Instruments
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- INFU Health Care
- PRE Industrials
- Exchange
- INFU Nasdaq
- PRE Nasdaq
- Market Cap
- INFU 104.4M
- PRE 105.4M
- IPO Year
- INFU N/A
- PRE N/A
- Fundamental
- Price
- INFU $5.67
- PRE $9.20
- Analyst Decision
- INFU
- PRE Buy
- Analyst Count
- INFU 0
- PRE 1
- Target Price
- INFU N/A
- PRE $9.00
- AVG Volume (30 Days)
- INFU 175.7K
- PRE 37.6K
- Earning Date
- INFU 05-08-2025
- PRE 06-17-2025
- Dividend Yield
- INFU N/A
- PRE N/A
- EPS Growth
- INFU 3654.89
- PRE N/A
- EPS
- INFU 0.15
- PRE N/A
- Revenue
- INFU $137,582,000.00
- PRE $30,621,000.00
- Revenue This Year
- INFU $11.08
- PRE $148.70
- Revenue Next Year
- INFU $8.02
- PRE $82.89
- P/E Ratio
- INFU $37.90
- PRE N/A
- Revenue Growth
- INFU 7.98
- PRE 40.83
- 52 Week Low
- INFU $4.61
- PRE $3.10
- 52 Week High
- INFU $9.97
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- INFU 53.66
- PRE 67.68
- Support Level
- INFU $5.08
- PRE $5.08
- Resistance Level
- INFU $5.83
- PRE $11.99
- Average True Range (ATR)
- INFU 0.29
- PRE 0.88
- MACD
- INFU -0.01
- PRE 0.18
- Stochastic Oscillator
- INFU 50.60
- PRE 59.51
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.